| |
PD with OH |
PD without OH |
p |
| Mean age (years) |
76.11 ± 9.41 |
65.9 ± 11.03 |
p=0.0415 |
| Gender |
|
|
|
| M |
8 (88%) |
5 (45%) |
p=0.0703 |
| F |
1 (12%) |
6 (55%) |
|
| Age at onset (years) |
71.44 ± 8.07 |
60.9 ± 12.87 |
p=0.0472 |
| Disease duration (years) |
4.66 ± 3.74 |
5 ± 2.93 |
p=0.8303 |
| SAH |
|
|
|
| Yes |
4 |
5 |
p=0.9640 |
| No |
5 |
6 |
|
| Dizziness and falls |
|
|
|
| Yes |
7 |
5 |
p=0.3129 |
| No |
2 |
6 |
|
| Duration of L-dopa use |
3.77 ± 2.04 |
3.77 ± 2.62 |
p=0.9962 |
| Duration of disease before L-dopa started |
1.22 ± 2.01 |
0.88 ± 1.96 |
p=0.7101 |
|
